|
|
Buruli ulcer and antibiotics
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.
Vaccine
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
Clinical and vaccine immunology : CVI
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates.
Journal of virology
[Viruses and bats: rabies and Lyssavirus].
Bulletin et mémoires de l'Académie royale de médecine de Belgique
Filoviruses and the balance of innate, adaptive, and inflammatory responses.
Viral immunology
Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Journal of virology
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
Vaccine
Analysis of Ebola virus and VLP release using an immunocapture assay.
Journal of virological methods
Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges.
Virology
Filovirus-like particles as vaccines and discovery tools.
Expert review of vaccines
Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.
The Journal of infectious diseases
Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.
The Journal of infectious diseases
Ebola virus: immune mechanisms of protection and vaccine development.
Biological research for nursing
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
Nature
Ebola virus-like particles protect from lethal Ebola virus infection.
Proceedings of the National Academy of Sciences of the United States of America
Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues.
The Journal of infectious diseases
Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein.
Immunology letters
Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
Virology
Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
Journal of virology
Development of a preventive vaccine for Ebola virus infection in primates.
Nature
Vaccine
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
Clinical and vaccine immunology : CVI
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates.
Journal of virology
[Viruses and bats: rabies and Lyssavirus].
Bulletin et mémoires de l'Académie royale de médecine de Belgique
Filoviruses and the balance of innate, adaptive, and inflammatory responses.
Viral immunology
Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Journal of virology
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
Vaccine
Analysis of Ebola virus and VLP release using an immunocapture assay.
Journal of virological methods
Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges.
Virology
Filovirus-like particles as vaccines and discovery tools.
Expert review of vaccines
Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.
The Journal of infectious diseases
Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.
The Journal of infectious diseases
Ebola virus: immune mechanisms of protection and vaccine development.
Biological research for nursing
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
Nature
Ebola virus-like particles protect from lethal Ebola virus infection.
Proceedings of the National Academy of Sciences of the United States of America
Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues.
The Journal of infectious diseases
Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein.
Immunology letters
Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
Virology
Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
Journal of virology
Development of a preventive vaccine for Ebola virus infection in primates.
Nature
Get breaking news about nutritional cures, dangerous chemicals, superfoods and more.
Subscribe to the FREE Natural News email newsletter. Your privacy is protected.
See more studies on Buruli ulcer and...
How is this determined?
The order of these related concepts is determined by a statistical analysis of the scientific literature. Highest-frequency concepts appear first.
|
skin 174 tropical 74 Ulcers 49 Tuberculosis 49 water 44 Infectious 37 Necrotic 31 Inflammatory 30 Immunosuppressive 27 vaccination 23 Leprosy 22 antibiotics 21 Antimycobacterial 19 Cytotoxic 19 lead 16 blood 15 Antimicrobial 14 environment 14 fish 14 chemotherapy 13 HIV 12 Clarithromycin 9 amputation 8 Cytotoxicity 7 lymph nodes 7 Granuloma 7 |
Death 6 pain 6 Fat 6 Toxins 6 vaccines 6 Tumor 5 invertebrate 5 honey 5 Immune system 5 nerves 5 Immunomodulatory 5 Ciprofloxacin 5 Enzymes 5 Malaria 5 Sepsis 4 farming 4 salivary glands 4 Atrophy 4 AIDS 4 sodium 4 biodiversity 4 irrigation 4 Anthrax 4 Dengue 4 bones 4 |
